BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

  May 15, 2025

   · 

  5 min read
• Press Releases

  Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

  May 15, 2025

   · 

  15 min read
• Press Releases

  Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and EHA

  May 15, 2025

   · 

  19 min read
• Press Releases

  Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

  May 15, 2025

   · 

  9 min read
• Press Releases

  Omeros Corporation Reports First Quarter 2025 Financial Results

  May 15, 2025

   · 

  14 min read
• Press Releases

  QurAlis Announces Exclusive License on Novel Mechanism for Fragile X Syndrome (FXS) to Enable Development of First Potential Disease-Modifying Therapy

  May 15, 2025

   · 

  5 min read
• Press Releases

  OPKO Health to Participate in Two Upcoming Investor Conferences

  May 15, 2025

   · 

  1 min read
• Press Releases

  Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update

  May 15, 2025

   · 

  11 min read
• Press Releases

  Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig

  May 15, 2025

   · 

  12 min read
• Press Releases

  START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

  May 15, 2025

   · 

  2 min read